ES541295A0 - Procedimiento para preparar isocromanos y oxepinas, susti- tuidos - Google Patents

Procedimiento para preparar isocromanos y oxepinas, susti- tuidos

Info

Publication number
ES541295A0
ES541295A0 ES541295A ES541295A ES541295A0 ES 541295 A0 ES541295 A0 ES 541295A0 ES 541295 A ES541295 A ES 541295A ES 541295 A ES541295 A ES 541295A ES 541295 A0 ES541295 A0 ES 541295A0
Authority
ES
Spain
Prior art keywords
isocromanes
oxepines
substitutes
preparing
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES541295A
Other languages
English (en)
Other versions
ES8606324A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim GmbH
Original Assignee
Boehringer Ingelheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim GmbH filed Critical Boehringer Ingelheim GmbH
Publication of ES541295A0 publication Critical patent/ES541295A0/es
Publication of ES8606324A1 publication Critical patent/ES8606324A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76—Benzo[c]pyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES541295A 1984-03-16 1985-03-15 Procedimiento para preparar isocromanos y oxepinas, susti- tuidos Expired ES8606324A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843409612 DE3409612A1 (de) 1984-03-16 1984-03-16 Neue substituierte isochromane und oxepine, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
ES541295A0 true ES541295A0 (es) 1986-04-01
ES8606324A1 ES8606324A1 (es) 1986-04-01

Family

ID=6230653

Family Applications (1)

Application Number Title Priority Date Filing Date
ES541295A Expired ES8606324A1 (es) 1984-03-16 1985-03-15 Procedimiento para preparar isocromanos y oxepinas, susti- tuidos

Country Status (18)

Country Link
EP (1) EP0157206A3 (es)
JP (1) JPS60209581A (es)
KR (1) KR850006397A (es)
AU (1) AU4001785A (es)
CS (1) CS247196B2 (es)
DD (1) DD234421A5 (es)
DE (1) DE3409612A1 (es)
DK (1) DK120185A (es)
ES (1) ES8606324A1 (es)
FI (1) FI851022L (es)
GR (1) GR850658B (es)
HU (1) HUT37419A (es)
IL (1) IL74616A0 (es)
NO (1) NO851029L (es)
PH (1) PH20880A (es)
PL (1) PL252375A1 (es)
PT (1) PT80115B (es)
ZA (1) ZA851948B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3642331A1 (de) * 1986-12-11 1988-06-23 Basf Ag Basisch substituierte phenylacetonitrile, ihre herstellung und diese enthaltende arzneimittel
JPH03178952A (ja) * 1989-06-23 1991-08-02 Kyowa Hakko Kogyo Co Ltd アリールアルキルアミン誘導体
EP0450689A1 (en) * 1990-04-02 1991-10-09 Akzo Nobel N.V. New isochromane derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552004A (en) * 1976-05-26 1979-09-05 Takeda Chemical Industries Ltd Isochroman derivatives

Also Published As

Publication number Publication date
IL74616A0 (en) 1985-06-30
CS247196B2 (en) 1986-12-18
PL252375A1 (en) 1985-10-22
ES8606324A1 (es) 1986-04-01
FI851022A0 (fi) 1985-03-14
JPS60209581A (ja) 1985-10-22
EP0157206A2 (de) 1985-10-09
HUT37419A (en) 1985-12-28
PH20880A (en) 1987-05-27
DD234421A5 (de) 1986-04-02
AU4001785A (en) 1985-09-19
DK120185A (da) 1985-09-17
ZA851948B (en) 1986-11-26
PT80115B (de) 1987-03-24
NO851029L (no) 1985-09-17
PT80115A (de) 1985-04-01
EP0157206A3 (de) 1986-06-11
DK120185D0 (da) 1985-03-15
KR850006397A (ko) 1985-10-05
FI851022A7 (fi) 1985-09-17
GR850658B (es) 1985-07-11
FI851022L (fi) 1985-09-17
DE3409612A1 (de) 1985-09-19

Similar Documents

Publication Publication Date Title
ES544204A0 (es) Procedimiento para preparar dialcoxipiridinas
ES542976A0 (es) Procedimiento para preparar pirrolo-bencimidazoles
ES553989A0 (es) Procedimiento para preparar 2,2,6,6-tetraalquil-4-piperidilaminas
ES550730A0 (es) Procedimiento para preparar poliesterpolioles
ES551282A0 (es) Un procedimiento para la preparacion de derivados de benzotiazol y benzotiofeno
ES549806A0 (es) Procedimiento para preparar pteridinas
ES529728A0 (es) Procedimiento para preparar amino-2-fenil-5-benzodiazepinas-1, 3
ES543973A0 (es) Procedimiento para preparar peptidos
MX162986B (es) Procedimiento para preparar n-formil-alfa-aspartil-fenilalanina
ES555561A0 (es) Procedimiento para preparar celalosporinas
ES554373A0 (es) Procedimiento para preparar nuevos 1,2,4-triazolo-carbamatos
MX161361A (es) Procedimiento para preparar 1,6-naftiridin-2(1h)-onas
ES539511A0 (es) Procedimiento para preparar nuevas 8 a-acilaminoergolinas
MX160612A (es) Procedimiento para preparar 3-carbonil-1-aminoalquil-1h-indoles
ES550961A0 (es) Procedimiento para preparar derivados azolilalquilicos
AR240313A1 (es) Procedimiento para preparar nuevas 1, 2-dihidro-5-acil-2-piridinonas
ES548237A0 (es) Procedimiento para preparar n6-bicicloadenosinas
ES537819A0 (es) Procedimiento para anchoar
ES544792A0 (es) Procedimiento para preparar colorantes monoazoicos o diazoi-cos
ES544622A0 (es) Procedimiento para preparar l-fenilalamina
ES545701A0 (es) Procedimiento para preparar 9-oxo-15 a-hidroxi-16-fenoxi y 16-fenoxi sustituido-17,18,19,20-tetranorprosta-4,5,13 (e)- trienoatos
ES522662A0 (es) Procedimiento para preparar piridil y quinolil-imidazolinonas.
MX162329A (es) Procedimiento para preparar acilhidrazonas sulfeniladas
ES544074A0 (es) Procedimiento para preparar naftoxacinas
MX159907A (es) Procedimiento para preparar cloro-o-nitroanilinas